Delivery Order SPE2DR25D2204-SPE2DR26FS19B
- Not listed
- The Defense Logistics Agency awarded a $4,789.17 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is set to be completed by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,323.73 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count) on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the DLA. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,551.16 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the companies' long-standing relationship supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,001.53 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $4,747.98 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets in quantities of 30, with an ultimate completion date of August 11, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Febuxostat 40 mg tablets (30-count units) under a firm fixed-price contract valued at $1,676.71. The contract, which is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), was competitively awarded with no set-aside designation. Performance will be executed from...
- The Defense Logistics Agency awarded a $1,633.20 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Febuxostat 80 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the vendor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.23 to AmerisourceBergen Drug Corp for the supply of Febuxostat 80 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was executed on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,598.46 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count packages) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order represents a non-set-aside award made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.30 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on October 30, 2025, with completion targeted for October 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2204Indefinite Delivery Contract
- SPE2DR25D2204-SPE2DR26FS19BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,052.98 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected to fulfill this pharmaceutical requirement supporting military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this flexible contract structure, AmerisourceBergen Drug Corp supplies critical medical commodities to customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/4/25 |